We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China (RaTAPDR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02328118
Recruitment Status : Unknown
Verified August 2016 by JUNYAN ZHANG, The First People's Hospital of Xuzhou.
Recruitment status was:  Recruiting
First Posted : December 31, 2014
Last Update Posted : August 25, 2016
The First People's Hospital of Xuzhou
Information provided by (Responsible Party):
JUNYAN ZHANG, The First People's Hospital of Xuzhou

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : March 2017
Estimated Study Completion Date : May 2017